Contralateral breast cancer after radiotherapy among BRCA1 and BRCA2 mutation carriers: A WECARE Study Report

Overview of attention for article published in European Journal of Cancer (1965), May 2013

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (85th percentile)
Good Attention Score compared to outputs of the same age and source (74th percentile)

Mentioned by

twitter: 2 X users

guideline: 3 clinical guideline sources

Readers on

mendeley: 68 Mendeley

So far, Altmetric has seen 4 Guidelines that reference this research output.

Cancer risk‐reducing surgery: Brazilian society of surgical oncology guideline part 1 (gynecology and breast)

Clinical guideline published by Sociedade Brasileira de Cirurgia Oncológica (SBCO) on 11 Jun 2022

The Sociedade Brasileira de Cirurgia Oncológica (SBCO) is a non-profit civil society established in 1988, dedicated to uniting professionals in oncology treatment. Its mission focuses on continuous medical education, promoting early detection, prevention, and optimal treatment for cancer patients in Brazil.

ASTRO Radiation Therapy Summary of the ASCO-ASTRO-SSO Guideline on Management of Hereditary Breast Cancer

Clinical guideline published by American Society of Clinical Oncology (ASCO) on 21 May 2020

The American Society of Clinical Oncology (ASCO) is a leading organization dedicated to advancing cancer care through research, education, and clinical practice. ASCO provides evidence-based clinical guidelines to support oncologists in delivering optimal patient care and improving outcomes.

Management of Hereditary Breast Cancer: American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Guideline.

Clinical guideline published by American Society of Clinical Oncology (ASCO) on 03 Apr 2020

The Japanese Breast Cancer Society Clinical Practice Guideline for radiation treatment of breast cancer, 2015 edition

Clinical guideline published by Japanese Breast Cancer Society (JBCS) on 16 Feb 2016

The Japanese Breast Cancer Society (JBCS) is dedicated to advancing both basic and clinical research on breast cancer. It aims to enhance the education and clinical practice of its members, including physicians, while contributing to society's understanding of breast cancer.

This page shows the most recent posts that mention this research output. Click here to find out how to access more activity.